Stock Analysis on Net

Celgene Corp. (NASDAQ:CELG)

$22.49

This company has been moved to the archive! The financial data has not been updated since October 31, 2019.

Cash Flow Statement

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Celgene Corp., consolidated cash flow statement

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Net income
Depreciation
Amortization
Impairment charges
Deferred income taxes
Change in value of contingent consideration and success payments
Gain on sale of business
Net (gain) loss on sales of debt securities available-for-sale and equity investments
Fair value adjustments on equity investments
Share-based compensation expense
Share-based employee benefit plan expense
Derivative instruments
Other, net
Accounts receivable
Inventory
Other operating assets
Accounts payable and other operating liabilities
Income tax payable
Payment of contingent consideration
Deferred revenue
Change in current assets and liabilities, excluding the effect of acquisitions
Adjustments to reconcile net income to net cash provided by operating activities
Net cash provided by operating activities
Proceeds from sales of debt securities available-for-sale
Purchases of debt securities available-for-sale
Capital expenditures
Proceeds from sales of equity investment securities
Purchases of equity investment securities
Payments for acquisition of businesses, net of cash acquired
Other investing activities
Net cash used in investing activities
Payment for treasury shares
Proceeds from short-term borrowing
Principal repayments on short-term borrowing
Proceeds from the issuance of long-term debt
Repayments of long-term debt
Net proceeds (payments) from common equity put options
Payment of contingent consideration
Net proceeds from share-based compensation arrangements
Excess tax benefit from share-based compensation arrangements
Net cash provided by (used in) financing activities
Effect of currency rate changes on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period

Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31).


Net Income
The net income exhibited fluctuations over the period, with an initial decrease from $2,000 million in 2014 to $1,602 million in 2015, followed by a rebound to $1,999 million in 2016. Thereafter, it showed significant increases to $2,940 million in 2017 and $4,046 million in 2018, indicating strong profitability growth in the latter years.
Depreciation and Amortization
Depreciation expenses steadily increased from $104 million in 2014 to $160 million in 2018. Amortization expenses also grew overall, from $269 million in 2014 to $475 million in 2018, though with some volatility, notably a decline in 2017 compared to 2016.
Impairment Charges
Impairment charges showed considerable volatility, with a moderate figure of $133 million in 2014, declining in 2015, then sharply increasing to $489 million in 2016 and peaking at $1,679 million in 2017, before dropping significantly to $31 million in 2018. This suggests irregular recognition of significant impairments predominantly in 2017.
Deferred Income Taxes
Deferred income taxes fluctuated notably, displaying negative values primarily from 2014 to 2017, with a substantial negative spike in 2017 (-$1,330 million). In 2018, the figure turned positive to $32 million, reflecting changes in tax timing differences or adjustments.
Contingent Consideration and Related Payments
The change in contingent consideration and success payments was mostly negative or low, with a notable large negative adjustment of -$1,350 million in 2017. Payments for contingent consideration occurred irregularly with small negative values over several years, indicating acquisitions or liabilities settlements.
Investment Gains and Fair Value Adjustments
Gains on sale of debt securities and equity investments showed variable gains and losses, including a significant loss of -$84 million in 2015. A large negative fair value adjustment on equity investments was recorded in 2018 (-$317 million), indicating a marked decline in valuation that year.
Share-Based Compensation and Employee Benefits
Share-based compensation expenses showed a consistent upward trend, increasing substantially from $448 million in 2014 to $921 million in 2018. Conversely, share-based employee benefit plan expenses remained relatively stable, hovering around the $30-$40 million range annually.
Derivative Instruments and Other Items
Derivative instrument results fluctuated with a loss in 2014 and 2015, a gain in 2016 and 2017, and a small gain in 2018, indicating variable impact from derivative activities. Other net items remained minor and relatively stable over the years.
Working Capital Changes
Accounts receivable changes showed negative cash flow impact until 2017, improving slightly in 2018. Inventory changes were negative or minimal until a positive change of $82 million in 2018. Other operating assets and liabilities exhibited volatility, with accounts payable showing large positive inflows in 2015 and 2016 but declining afterward. Income tax payable had a significant positive increase in 2017 followed by a large negative correction in 2018. Deferred revenue steadily increased but remained minor in scale. The substantial positive change in current assets and liabilities in 2017 (+$2,171 million) contrasts with negative changes in adjacent years.
Cash Flow from Operating Activities
Net cash provided by operating activities increased steadily from $2,806 million in 2014 to a peak of $5,246 million in 2017, slightly declining to $5,171 million in 2018. Adjustments to reconcile net income to net cash showed a similar increasing trend until 2017, declining moderately in 2018, reflecting operational cash flow strength.
Investing Activities
Investing activities generally consumed cash, with net cash used fluctuating significantly. Payments for acquisitions notably impacted 2015 and 2018 with large outflows (-$7,695 million and -$8,648 million, respectively), contributing to the high cash usage. Purchases and sales of debt and equity securities and capital expenditures also contributed variably, with capital expenditures rising modestly from $150 million in 2014 to $330 million in 2018.
Financing Activities
Payments for treasury shares represented significant outflows consistently increasing from $2,975 million in 2014 to $6,096 million in 2018, indicating substantial share repurchase activity. Borrowing activities showed large and fluctuating short-term borrowings and repayments, with notable issuance of long-term debt in 2015 ($7,913 million) and moderate issuance in subsequent years. Overall, net cash flow from financing activities was positive in 2015 but negative in other years, reflecting major outflows related to debt repayment and share repurchases.
Cash and Equivalents
Cash and cash equivalents generally increased from 2014 ($4,122 million) to 2017 ($7,013 million), followed by a sharp decline to $4,234 million in 2018. The net increase in cash was positive until 2017, turning negative in 2018 (-$2,779 million), likely influenced by investing and financing outflows.
Overall Summary
The financial data reveals a company with increasing profitability and operational cash flow through 2017, coupled with significant investing activity, especially acquisitions and capital expenditures, which led to high cash outflows in investing. The company engaged heavily in share repurchases and managed debt with fluctuating borrowings and repayments. Cash reserves built up until 2017 but decreased substantially in 2018. Volatility in impairment charges, deferred taxes, and contingent considerations highlights episodic financial adjustments. The growing share-based compensation expense indicates increasing employee incentive costs over time.